ADAPADAP
World AIDS Day: More Funding for HIV Cure, Global Fund, No One on ADAP Wait List
- Details
- Category: HIV Policy & Advocacy
- Published on Wednesday, 04 December 2013 00:00
- Written by Liz Highleyman
Acknowledging World AIDS Day on December 1, President Obama announced that the National Institutes of Health (NIH) would reallocate $100 million over the next 3 years towards HIV cure research and donate up to $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria. In other funding news, NASTAD announced last week that there are currently no people with HIV on AIDS Drug Assistance Program (ADAP) waiting lists.
ADAP Crisis Task Force and ViiV Agree on Discounted Price for Dolutegravir
- Details
- Category: ADAP
- Published on Tuesday, 27 August 2013 00:00
- Written by NASTAD
The ADAP Crisis Task Force (ACTF) announced this week that it has negotiated an agreement with ViiV Healthcare to provide the newly approved integrase inhibitor dolutegravir (Tivicay) to AIDS Drug Assistance Program (ADAP) recipients for less than the wholesale cost.
Increased Federal Funding Will Eliminate ADAP Wait Lists
- Details
- Category: ADAP
- Published on Friday, 20 July 2012 00:00
- Written by Liz Highleyman
In advance of the International AIDS Conference in Washington, DC, Health and Human Services Secretary Kathleen Sebelius announced that the federal government has allocated nearly $800 million in additional funding for domestic HIV/AIDS programs, which should allow everyone now on state waiting lists to access treatment.
HIV Medical Providers Call for Fair Drug Pricing to Expand Access to Treatment
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 December 2012 00:00
- Written by Liz Highleyman
Practitioners from the American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA) delivered a joint statement to pharmaceutical company executives this week, asking the industry to reconsider its pricing for antiretroviral drugs so that more people in the U.S. and worldwide are able to access treatment. 
Companies Lower HIV Drug Prices for ADAP, but Many Patients Still Waiting
- Details
- Category: ADAP
- Published on Tuesday, 27 December 2011 00:00
- Written by Liz Highleyman
Four pharmaceutical companies recently agreed to discount their prices on 
antiretroviral drugs for AIDS Drug Assistance Programs (ADAPs), which are under increasing pressure due to the ongoing financial crisis. More than 4000 people with HIV are currently on ADAP waiting lists, most of them in the Southeast U.S.
More Articles...
- Obama Raises Domestic HIV Treatment Funding by $50 Million
- ADAP Waiting List Exceeds 9000 for the First Time
- Latest ADAP Numbers Show More than 1400 People on Waiting Lists in 11 States
- Gilead, ViiV Healthcare Announce Agreements with ADAP Crisis Task Force for Further Drug Discounts
- ADAP Waiting List Exceeds 1000; Drug Companies Agree to Price Freezes and Expanded Patient Assistance Programs
- California AIDS Advocates Demand that Governor Schwarzenegger Not Cut Funds for State AIDS Drug Assistance Program
Web Design and Development by